Determination of reference intervals of healthy adults aged between 20-50 years in Izmir;Izmirİlinde 20-50 yaş arası saǧlıklı bireylerde referans aralıklarının saptanması

Turkish Journal of Biochemistry

Volumn 35, Issue 3, 2010, Pages 215-224

  Köseoǧlu, Mehmet ^a   Işleten, Figen ^b   Dursun, Seyhun ^a   Çuhadar, Serap ^a  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Behçet Uz Education and Research Hospital   (Turkey)

Author keywords

Direct method; Nonparametric; Reference limits; Turkish population

Indexed keywords

ADULT; ANALYTIC METHOD; ARTICLE; CLINICAL CHEMISTRY; CLINICAL PRACTICE; FEMALE; HEALTH STATUS; HUMAN; MALE; PHYSICAL EXAMINATION; QUESTIONNAIRE; REFERENCE VALUE; TURKEY (REPUBLIC);

EID: 78449250748     PISSN: None     EISSN: 1303829X     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Clinical Laboratory and Standards Institude. (2000) How to define and determine reference intervals in the clinical labora tory; approved guideline-second edition. CLSI document 28-A2. Wayne, PA: 24.
2. Solberg HE. (2006) Establishment and use of reference values. Tietz Textbook of Clinical Chemistry, 4th ed. (Editors: Burtis CA, Ashwood ER), s. 425-448, WB Saunders Company, Philadelphia.
3. Solberg HE. (2004) The IFCC recommendation on estimation of reference intervals. The Refval Program. Clin Chem Lab Med. 42 (7): 710-714.
4. Solberg HE, Petit Clerc C. (1988) International Federation of Clinical Chemistry (IFCC), Scientific Committee, Clinical Section. Expert Panel on Theory of Reference Values (EPTRV). Approved recommendation on the theory of reference values. Part 3. Preparation of individuals and collection of specimens for the production of reference values. J Clin Chem Clin Biochem. 26: 593-598.
5. Solberg HE, Stamm D. (1991) International Federation of Clinical Chemistry (IFCC), Scientific Comittee, Clinical Section. Expert Panel on Theory of Reference Values (ERTRV). Approved recommendation (1991) on the theory of reference values. Part 4. Control of analytical variation in the production, transfer and application of reference values. Eur J Clin Chem Clin Bio-chem. 29: 531-535.
6. Gräsbeck R. (2004) The evolution of reference value concept. Clin Chem Lab Med. 42 (7): 692-697.
7. Solberg HE. (1987) Approved recommendation on the theory of reference values: part 1.the concept of reference values. J Clin Chem Clin Biochem. 25: 337-342.
8. Laleli Y, Akbay A. (2000) Referans arali{dotless}k analizi. Ti{dotless}bbi laborat-uarlarda standardizasyon ve kalite yönetimi. (Derleyenler: Taga Y, Aslan D, Güner G, Kutay FZ), s.124-137, Mart Matbaaci{dotless}li{dotless}k.
9. National Committee for Clinical Laboratory Standards. (1995) How to define and determine reference intervals in the clinical laboratory; approved guideline, NCCLS C28-A, Wayne, PA.
10. Lott AJ, Mitchell CL, Moeschberger ML, Sutherland DE. (1992) Estimation of reference ranges: how many subjects are needed? Clin Chem. 38 (5): 648-650.
11. Lahti A, Hyltoft Peterson P, Boyd JC, Fraser CG, Jørgensen N. (2002) Objective criteria for partitioning gaussian-distributed reference values into subgroups. Clin Chem. 48: 338-352.
12. Lahti A, Hyltoft Peterson P, Boyd JC, Rustad Pål, Laake P, Solberg HE. (2004) Partitioning of nongaussian-distributed biochemical reference data into subgroups. Clin Chem. 50 (5): 891-900.
13. Horn PS, Feng L, Li Y, Pesce AJ. (2001) Effect of outliers and nonhealthy individuals on reference interval estimation. Clin Chem. 47 (12): 2137-2145.
14. Reed AH, Henry RJ, Mason WB. (1971) Influence of statistical method used on the resulting estimate of normal range. Clin Chem. 17: 275-284.
15. Ichihara K, Itoh Y, Min WK, Sook FY, Lam CWK, Kong XT, Chou CT, Nakamura H. (2004) Diagnostic and epidemiolog-ical implications of regional differences in serum concentrations of proteins observed in six Asian cities. Clin Chem Lab Med. 42: 800-809.
16. Ichihara K, Itoh Y, Lam CWK, Poon MKP, Kim JH, Kyo-no H, Chandrawening N, Mullaty D and Science Committee for the APFCB.(2008) Source of variation of commonly measured serum analytes in 6 Asian cities and consideration of common reference intervals. Clin Chem. 54(2): 356-365.
17. Painter CP, Cope JT, Smith MS. (1999) Reference information for the clinical laboratory. Tietz Textbook of Clinical Chemistry, 3th ed. (Editors: Burtis CA, Ashwood ER), s. 1799-1839, WB Saunders Company, Philadelphia.
18. Ilcol YO, Aslan D. (2004) Determining reference value of blood chemistry profile in healthy subjects in Bursa. Turk J Biochem. 29: 183-192.
19. Enli Y, Aslan D, Akalin N, Aydin Y, Yilmazturk G, Goçhan I, Tekintürk S, Demir S. (2003) Determination of reference intervals for 18-40 years old people living in Denizli by using different methods. Turk J Biochem. 28: 228-245.
20. Gietka-Czernel M, Jastrzebska H. (2007) Thyrotropin reference range- should it be changed? Endokrynol Pol. 58 (5): 454-460.
21. Quinn FA, Tam MC, Wong PT, Poon PK, Leung MS. (2009) Thyroid autoimmunity and thyroid hormone reference intervals in apparently healthy Chinese adults. Clin Chim Acta. 405 (1-2): 156-159.
22. Zöphel K, Wunderlich G, Kotzerke J. (2006) Should we really determine a reference population for the definition of thyroid-stimulating hormone reference interval? Clin Chem. 52 (2): 329-330.
23. Rustad P, Felding P, Franzson L, Kairisto V, Lahti A, Mårtens-son A, Petersen H, Simonsson P, Steensland H, Uldall A. (2004) The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical properties. Scan J Clin Lab Invest. 64 (4): 271-284.
24. Rustad P, Felding P, Lahti A, Hyltoft Peterson P. (2004) Descriptive analytical data and consequences for calculation of common reference intervals in the Nordic Reference Interval Project 2000. Scan J Clin Lab Invest. 64: 343-370.
25. Schumann G, Klauke R. (2003) New IFCC reference procedure for the determination of catalytic activity concentrations of five enzymes in serum: preliminary upper reference limits obtained in hospitalized subjects. Clin Chim Acta. 327: 69-79.
26. National Cholesterol Education Program (2002). Third Report of the Expert Panel on Detection, Evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 106: 3143-3421.
27. Mahley RW, Palaoglu KE, Atak Z, Dawson-Pepin J, Langlois AM, Cheung V, Onat H, Fulks P, Mahley LL, Vakar F. (1995) Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J. Lipid Res. 36: 839-859.
28. Luttmann S, von Eckardstein A, Wei W, Funke H, Kohler E, Mahley RW, Assmann G. (1994) Electrophoretic screening for genetic variation in apolipoprotein C-III: identification of a novel apoC-III variant, apoC-III(Asp45-->Asn), in a Turkish patient. J Lipid Res. 35: 1431-1440.
29. Koycu B, Kara T, Camlidag O, Aydinli R, Verschuren WM, van Montfrans GA. (1997) Risk factors for cardiovascular diseases in Turks in Amsterdam and in Ankara. Ned Tijdschr Geneeskd. 141 (18): 882-888.
30. Assmann G, Schulte H. (1992) Relation of high-density lipopro-tein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study. Am. J. Cardio. 70 (7): 733-737.
31. Bersot TP, Vega GL, Grundy SM, Palaoglu KE, Atagunduz P, Ozbayrakci S, Gökdemir O, Mahley RW. (1999) Elevated hepatic lipase activity and low levels of high density lipoprotein in a normotriglyceridemic, nonobese Turkish population. J Lipid Res. 40 (3): 432-438.